Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00914550 · ClinicalTrials.gov registry record

Use Of Procalcitonin Level For Guidance of The Treatment of Suspected Community Acquired Pneumonia

A clinical trial, sponsored by Winthrop University Hospital.

Completed
Registry status
47
Enrollment target

NCT00914550: Completed study, sponsored by Winthrop University Hospital.

NCT00914550 is a clinical trial that has completed, run by Winthrop University Hospital. The registered enrollment target is 47 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00914550 has completed, sponsored by Winthrop University Hospital.

COMPLETED
Registry status
47 participants
Enrollment target

Study Summary

The purpose of the study is to learn if a blood test is helpful to the doctors in deciding whether you need antibiotic therapy for possible pneumonia. The blood test is called a Procalcitonin level and sometimes the test reflects infection with certain bacteria (germs). When the doctors learn the results of these blood tests, they may be able to stop some of the antibiotic medications that they may have given to the patients. The study is designed, so that on a randomized basis (50/50 chance) the results from measuring Procalcitonin will be given to the patients' doctor. When the doctor receives these results, he/she may use this information, along with other information, to decide whether to continue antibiotic therapy.

Interventions

  • OTHER Procalcitonin level, caregiver informed

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2009-06
Est. Completion 2012-09
Winthrop University Hospital

32 total trials

What the finished NCT00914550 record still lists

NCT00914550 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 47 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Procalcitonin level, caregiver informed is the first listed.

NCT00914550 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00914550 about?

NCT00914550 is a clinical study titled "Use Of Procalcitonin Level For Guidance of The Treatment of Suspected Community Acquired Pneumonia". The purpose of the study is to learn if a blood test is helpful to the doctors in deciding whether you need antibiotic therapy for possible pneumonia. The blood test is called a Procalcitonin level and sometimes the test reflects infection with certain bacteria (germs). When the doctors learn the re...

What is the current status of trial NCT00914550?

This trial is currently completed. The enrollment target is 47 participants. The study started on 2009-06. Estimated completion is 2012-09.

What interventions are being tested in trial NCT00914550?

The interventions under investigation include: Procalcitonin level, caregiver informed (OTHER).

Who is sponsoring clinical trial NCT00914550?

This trial is sponsored by Winthrop University Hospital, which has 32 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03313011 · 47 participants

    The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech

  • NCT03467516 · 47 participants · Phase 2

    Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma

  • NCT03886662 · 47 participants · Phase 1

    A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)

  • NCT04013802 · 47 participants · Phase 1

    TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00914550, the US trial registry maintained by the National Library of Medicine. NCT00914550 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.